There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the ...

Being a young adult cancer survivor is bittersweet, bringing both unique struggles and unexpected blessings that shape my ...

Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...

An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...